Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 3100 of 3173 entries
View as:

Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00312364 Org: User:
Start: 12/31/05 End: 12/31/07 Due: 12/31/08

A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01320085 Org: User:
Start: 03/24/11 End: 02/06/23 Due: 02/06/24

A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06495164 Org: User:
Start: 07/03/24 End: 12/31/26 Due: 12/31/27

A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01525550 Org: User:
Start: 06/06/12 End: 07/26/18 Due: 07/26/19

Bioavailability Study Of PF-06651600 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02684760 Org: User:
Start: 02/29/16 End: 05/31/16 Due: 05/31/17

Fesoterodine "add-on" Male Overactive Bladder Study

Phase: N/A Priority: Normal
NCT ID: NCT00546637 Org: User:
Start: 11/30/07 End: 02/28/09 Due: 02/28/10

Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04962022 Org: User:
Start: 07/20/21 End: 09/30/21 Due: 09/30/22

Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT00607256 Org: User:
Start: 10/20/07 End: 05/18/09 Due: 05/18/10

Study of SU011248 in Patients With Advanced Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00254540 Org: User:
Start: 12/31/05 End: 02/28/09 Due: 02/28/10

Fecal Recovery of the Probiotic Bacteria Lactobacillus Rhamnosus GG (LGG) and Bifidobacterium Animalis Subspecies Lactis BB-12 (BB-12) in Healthy Humans Following Daily Consumption of a Probiotic Supplement

Phase: N/A Priority: Normal
NCT ID: NCT01757054 Org: User:
Start: 02/28/13 End: 10/31/13 Due: 10/31/14

A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01314898 Org: User:
Start: 03/31/11 End: 06/30/11 Due: 06/30/12

Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT02951156 Org: User:
Start: 12/16/16 End: 12/02/19 Due: 12/02/20

Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature

Phase: N/A Priority: Normal
NCT ID: NCT00396097 Org: User:
Start: 12/31/06 End: 08/31/12 Due: 08/31/13

Efficacy Of PF-05089771 In Treating Postoperative Dental Pain

Phase: N/A Priority: Normal
NCT ID: NCT01529346 Org: User:
Start: 12/12/11 End: 06/25/12 Due: 06/25/13

Study of Single Ascending Doses of PF-07081532 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04148209 Org: User:
Start: 11/05/19 End: 03/17/20 Due: 03/17/21

Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

Phase: N/A Priority: Normal
NCT ID: NCT00459706 Org: User:
Start: 09/30/07 End: 09/30/09 Due: 09/30/10

A Study to Learn About if the Study Medicine Called Ibuzatrelvir Changes How the Body Process the Other Medicine Dabigatran Etexilate in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06693518 Org: User:
Start: 11/22/24 End: 01/15/25 Due: 01/15/26

Safety And Efficacy Of Rifabutin In HIV Patients

Phase: N/A Priority: Normal
NCT ID: NCT00810446 Org: User:
Start: 06/30/09 End: 03/31/18 Due: 03/31/19

Compliance And Safety Study In Children With Upper And Lower Respiratory Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT00939185 Org: User:
Start: 04/30/07 End: 01/31/09 Due: 01/31/10

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00277238 Org: User:
Start: 02/28/06 End: 07/31/07 Due: 07/31/08

A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00649311 Org: User:
Start: 04/30/03 End: 09/30/03 Due: 09/30/04

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT03307980 Org: User:
Start: 06/22/17 End: 06/08/29 Due: 06/08/30

A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00569972 Org: User:
Start: 10/31/07 End: 01/31/09 Due: 01/31/10

Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00570063 Org: User:
Start: 11/30/07 End: 02/18/08 Due: 02/18/09

A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market

Phase: N/A Priority: Normal
NCT ID: NCT06760208 Org: User:
Start: 09/01/25 End: 10/30/28 Due: 10/30/29